Josh Wolfe, Director, 10% Owner at Eikon Therapeutics, Inc. (EIKN), bought 2,294,653 shares at $18.00 ($2.5M) on 2026-02-04, disclosed to the SEC on 2026-02-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.00 | 138,888 | $2.5M | 100.0% |
| 2 | $0.00 | 2,155,765 | $0 | 0.0% |
| Total | $1.09 avg | 2,294,653 | $2.5M | 100% |